Vitiligo: modern methods of therapy

Bibliography:
1. Afsheen В, Irfan A. Guidelines for the management of vit-iligo. Journal of Pakistan Association of Dermatologists 2014; 24 (1): 68-78
2. Kunisada M, Kumimoto H, Ishizaki K. Narrow-band UVB induces more carcinogenic skin tumors than broad-band UVB through the formation of cyclobutane pyrimidine dimer. J Invest Dermatol 2007; 127: 2865-71
3. Hann SK, Lee HJ. Segmental vitiligo: clinical findings in 208 patients. J Am Acad Dermatol 1996; 35: 671-4
4. Federal Clinical Practice Guidelines for the Management of Patients with Vitiligo. Moscow, 2015; 16 p. Russian (Федеральные клинические рекомендации по ведению больных с витилиго. М., 2015; 16 с.
5. Ghafouriani Е, Ghafouriani S, Sadeghifard N. Vitiligo: symptoms, pathogenesis and treatment. International Journal of Immunopathology and Pharmacology 2014; 27 (4): 485-489
6. Taieb A, Alomar A, Bbhm M. Guidelines for the Management of Vitiligo. The British Journal of Dermatology 2013; 168 (1): 5-19
7. Bellet JS, Prose NS. Vitiligo in children: a review of classification, hypotheses of pathogenesis and treatment. Ann Bras Dermatol 2005; 80 (6): 633-7
8. Latanya Т. B. Light-Based Procedures in Pediatric Dermatology. Therapy in Pediatric Dermatology 2017: 459-62
9. Amanjot KA, Sunil D. Narrowband ultraviolet В and beyond: Evolving role of phototherapy in vitiligo. Pigment International 2015; 2 (1): 9-20
10. Davinder P, Abha B, Dipankar D. Narrowband ultraviolet В for the treatment of vitiligo. Expert Rev Dermatol 2010; 5 (4): 445-59
11. Westerhof W, Nieuweboer-Krobotova L. Treatment of vitiligo with UV-B vs topical psoralen plus UV-A. Arch. Dermatol 1997; 133: 1525-8
12. Beissert S, Schwarz T. Role of immunomodulation in diseases responsive to phototherapy. Methods 2002; 28: 138-44
13. El-Ghorr AA, Norval M. Biological effects of narrow-band (311 nm TL01) UVB irradiation: a review. J Photochem PhotobiolB 1997;38:99-106
14. Fitzpatrick ТВ. Mechanisms of phototherapy of vitiligo. Arch Dermatol 1997; 133: 1591-2
15. Guckian M, Jones CD, Vestey JP Immunomodulation at the initiation of phototherapy and photochemotherapy. Photo-dermatol Photoimmunol Photomed 1995; 11: 163-9
16. Hruza LL, Pentland AP Mechanisms of UV-induced inflammation. J Invest Dermatol 1993; 100: 35-41
17. Moodycliffe AM, Kimber I, Norval M. The effect of ultraviolet В irradiation and urocanic acid isomers on dendritic cell migration. Immunology 1992; 77: 394-9
18. Lim HW, Carucci JA, Spencer JM. Commentary: A responsible approach to maintaining adequate serum vitamin D levels. J Am Acad Dermatol 2007; 57: 59-5
19. Bhargava P, Prakash C, Tiwari S. Correlating melanin index to repigmentation potential: A novel prognostic tool in vitiligo. Pigment Int 2016; 3: 72-6
20. Haider RM, Grimes PE, Cowan CA. Childhood vitiligo. J Am Acad Dermatol 1987; 16: 948-54
21. Kanwar AJ, Dogra AJ. Narrow-band UVB for the treatment of generalized vitiligo in children. Clin Exp Dermatol 2005; 30: 332-6
22. Kanwar AJ, Dogra S., Parsad D. Narrow-band UVB for the treatment of vitiligo: an emerging effective and well-tolerated therapy. Int J Dermatol 2005; 44: 57
23. Nicolaidou E, Antoniou C, Stratigos AJ. Efficacy, predictors of response, and long-term follow-up in patients with vitiligo treated with narrowband UVB phototherapy. J Am Acad Dermatol 2007; 56: 274-8
24. Njoo MD, Bos JD, Westerhof W. Treatment of generalized vitiligo in children with narrow-band (TL-01) UVB radiation therapy. J Am Acad Dermatol 2000; 42: 245-53
25. Hamblin MR, Huang YY. Handbook of photomedicine. CRC Press 2014: 815
26. Pugashetti R, Lim H, Koo J. Broadband UVB revisited: Is the narrowband UVB fad limiting our therapeutic options? J Dermatolog Treat 2010; 21 (6): 326-30
27. Seo SL, Kim IH. Squamous cell carcinoma in a patient with generalized vitiligo. J Am Acad Dermatol 2001; 45: 227-9
28. Man I, Crombie IK, Dawe RS. The photocarcinogenic risk of narrowband TL-01 ultraviolet В therapy: early follow up data. Br J Dermatol 2005; 152: 755-7
29. Medhat E-M, Wedad M, Samia E. Phototherapy in vitiligo: a comparative evaluation of various therapeutic modalities. Journal of the Egyptian Women's Dermatologic Society 2012; 9: 123-35
30. Pacifico A, Leone G. Photo (chemo) therapy for vitiligo. Photodermatol Photoimmunol Photomed 2011; 27: 261-77
31. Cui J, Shen LY, Wang GC. Role of hair follicles in the repigmentation ofvitiligo. J Invest Dermatol 1991; 97: 410-6
32. Stern R. The risk of squamous cell and basal cell cancer associated with psoralen and ultraviolet A therapy: A 30-year prospective study. J Am Acad Dermatol 2012; 4; 1 -10
33. Brazelli V, Prestinari F, Castello M. Useful treatment ofvitiligo in 10 children with UV-B Narrowband (311 nm). Pediatr Dermatol 2005; 22: 257-61
34. Leone G, lacovelli P, Paro V.A. Monochromatic exci-mer light 308 nm in the treatment ofvitiligo: a pilot study. J Eur Acad Dermatol Venereol 2003; 17: 531-7
35. Vangipuram R, Feldman SR. Ultraviolet phototherapy for cutaneous diseases: a concise review. Oral Diseases 2015: 1-7
36. Mohammed ZRB, GaziAS. Effect of Topical Tacrolimus on Vitiligo in Children. J Enam Med Col 2016; 6 (1): 33-7
37. Zhang Y, Mooneyan-Ramchurn JS, Zuo N. Vitiligo non-surgical treatment: a review of latest treatment researches. Dermatologic Therapy 2014; 2: 1 -6
38. Kovacs D, Abdel-Raouf H, Al-Khayyat M. Vitiligo: characterization of melanocytes in repigmented skin after punch grafting. JEADV 2014: 1-10
39. Lisa ВТ, Jeffrey MW, Nanette BS. Successful Treatment ofVitiligo with 0.1% Tacrolimus Ointment. Arch Dermatol 2003; 139:571-4.